27.2 C
Vientiane
Wednesday, September 3, 2025
spot_img
Home Blog Page 805

GEEKOM Targets Korea with High-Performance Mini PCs

TAIPEI, April 29, 2025 /PRNewswire/ — GEEKOM, a Taiwanese tech company known as the Green Mini PC Global Leader, has announced its strategic focus on South Korea as a major target market in 2025, unveiling multiple cutting-edge models designed to cater to diverse computing needs. This move underscores GEEKOM‘s commitment to expanding its presence in Asia and delivering innovative solutions to tech-savvy consumers.

Mini PCs offer a compact, space-saving alternative to traditional desktop towers, making them ideal for modern workspaces or smaller living environments. Despite their size, mini PCs often deliver impressive performance, integrating advanced processors and storage solutions. They consume less power, reducing electricity bills and environmental impact. Known for their outstanding quality, GEEKOM Mini PCs are popular in markets including USA, Western Europe and Australia.

Most of GEEKOM‘s popular models are now available for purchase on Coupang and Naver, including those recently showcased at CES 2025. Leading the lineup is the fan-favorite GEEOM IT13 2025 Edition, equipped with an Intel Core i9-13900HK processor, dual-channel DDR4-3200MHz RAM and a fast PCIe Gen4 SSD. Thanks to its powerful performance and unmatched versatility, the IT13 2025 Edition is well-suited for all sorts of computing scenarios.

Another high-performance solution is the A8 MAX. Equipped with the AMD Ryzen 9 8945HS processor and Radeon 780M iGPU, it delivers exceptional performance for demanding chores like 4K video editing, graphic design, and multitasking. Its built-in NPU enhances AI-driven applications, offering up to 60% faster performance for compatible software. With dual USB4 ports, the mini PC even supports external GPUs for even greater versatility, perfect for creative professionals and tech enthusiasts seeking top-tier performance in a sleek design.

For budget-conscious users, the GEEKOM A6 provides an affordable yet powerful alternative. Priced below $500, it features AMD’s Ryzen R7-6800H processor and shares many of the A8 Max’s core functionalities, including extensive connectivity and storage options. This model is extremely appealing to users seeking value without compromising on performance.

GEEKOM‘s decision to target South Korea aligns with the country’s reputation as a hub for technological innovation and consumer demand for high-quality electronics. By introducing these models, GEEKOM aims to capture the attention of Korean consumers who prioritize performance, reliability, and cutting-edge design.

As GEEKOM continues to innovate, its focus on Korea signals a promising future for the brand in one of the world’s most dynamic tech markets.

 

Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025

SHANGHAI, April 29, 2025 /PRNewswire/ — Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech specializing in developing innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies for cancer, today announced it will present preclinical data on a feeder-free manufacturing process for IL-2-independent TIL expansion at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), taking place May 13–15, 2025, in New Orleans, LA.

The study highlights Juncell Therapeutics’ breakthroughs in TIL process development, demonstrating that its proprietary feeder-free system can generate robust, functional TILs from both “hot” and “cold” tumor tissues without relying on high-concentration interleukin-2 (IL-2). These TILs exhibited significant anti-tumor activity in syngeneic patient-derived organoid (PDO) and patient-derived xenograft (PDX) models. By eliminating IL-2 dependence and removing the need for feeder cells, the technology paves the way for safer TIL treatment regimens and reduces manufacturing costs.

Presentation Details:

Title: Development of A Feeder-Free Process for IL-2-Independent TIL Expansion
Poster Number: AMA362
Session: Thursday Poster Reception
Date and Time: May 15, 2025, 5:30 PM–7:00 PM
Location: Poster Hall Hall I2

About Juncell Therapeutics

Juncell Therapeutics is a biotech dedicated to developing high-quality, accessible IL-2 independent TIL therapies for the treatment of solid tumors. Juncell Therapeutics has established its proprietary DeepTIL® cell expansion and NovaGMP® gene modification technology platforms, which are designed to address the key challenges of conventional TIL therapies, making TILs “robust, competent, affordable, and accessible.” Two clinical-stage TIL therapies have demonstrated promising safety and efficacy in the treatment of ten types of heavily pretreated advanced solid tumors, including lung cancer, triple-negative breast cancer, pancreatic cancer, high-grade glioma, ovarian cancer, endometrial cancer, cervical cancer, head and neck cancer, bile duct cancer and melanoma.

For more information, please visit:

https://www.juncell.com/en

https://www.linkedin.com/company/juncell-therapeutics

Juncell Contact:

contact@juncell.com

LOTTE rent-a-car suggests a travel course following the famous scenes from the Netflix Series ‘When Life Gives You Tangerines’

  • LOTTE rent-a-car introduces Jeju travel destinations featured in the drama that captivated global viewers
  • Enhancing convenience for international travelers by providing dedicated staff for foreign customers and multilingual support
  • Offering various services such as chauffeur-driven rental cars, welcome coupon packs, and free electric vehicle charging

SEOUL, South Korea, April 29, 2025 /PRNewswire/ — As the Netflix series ‘When Life Gives You Tangerines’ receives an enthusiastic response from global viewers, interest in Jeju Island, known as the ‘Hawaii of Korea’ and the backdrop of the drama, is increasing. With the peak travel season to Jeju from March to May, the number of foreign tourists looking to experience the unique nature of Jeju depicted in the drama is on the rise.

Jeju Island has many hidden gems that are difficult to access using public transportation alone, making rental cars essential. LOTTE rent-a-car, South Korea’s No.1 rental car brand, holds the top market share in the Korean rental car market and is the official partner of the global rental car brand Hertz, providing verified services. They offer a systematic service system and multilingual support platform for international customers.

LOTTE rent-a-car Jeju Auto House is located near Jeju International Airport. It is the largest single-location rental car facility in the country, with a fleet of 3,000 vehicles. Operating 365 days a year from 6 AM to 11 PM, it allows customers to pick up or return vehicles conveniently regardless of flight times. The proportion of foreign customers renting from LOTTE rent-a-car in Jeju is increasing every year. As of 2024, foreign customers account for 25.6% of the total customers at LOTTE rent-a-car Jeju Auto House, meaning one in four customers is a foreigner.

For international tourists planning a trip to Jeju in the first half of this year, LOTTE rent-a-car suggests a special Jeju travel course centered around the filming locations of iconic scenes from the drama. These include Gimnyeong Beach, where young Aesoon eagerly waited for her mother, and Seongsan Ilchulbong, which showcases the beautiful scenery of Jeju.

Gimnyeong Beach: A Pristine Beach Embodying the Lives of female divers

Located in eastern Jeju, Gimnyeong Beach gained attention as the setting for the lives of haenyeo(female divers) in the drama. The exotic landscape, where cobalt blue waters, white sandy beaches, and black basalt rocks harmonize, leaves visitors in awe. Not only can you experience the local haenyeo culture, but you can also enjoy various marine activities such as yachting, kayaking, and snorkeling. The walking trail along the wind turbines lined up on the eastern side of the beach and the nearby cave exploration course add a unique charm.

Seongsan Ilchulbong: A UNESCO World Heritage Site and Sunrise Spot

Seongsan Ilchulbong, where the protagonist Aesoon performs 3,000 bows in the drama, is one of Jeju’s most iconic natural landmarks. Formed by underwater volcanic activity about 5,000 years ago, its cratered terrain is notable. This site is recognized as a UNESCO World Natural Heritage due to its geological significance and is also famous for its breathtaking sunrise views over the open sea. The magnificent scenery, where the blue sea and cliffs blend, leaves a lasting impression on both drama fans and general tourists.

Ora-dong Buckwheat Field: A Healing Photo Spot with Different Faces Each Season

The buckwheat flower path where Aesoon and Gwansik shared memories in the drama was filmed in the buckwheat fields of Ora-dong, Jeju City. The vast field, equivalent to 130 soccer fields, offers different charms each season, making it an ideal photo spot, especially for wedding photos. In spring, yellow canola flowers, in summer, pure white buckwheat flowers adorn the field, and from late winter to spring, the landscape is filled with green barley and reeds. May and June are the best times to witness the most splendid scenery.

Jejumok Gwana: Where Aesoon and Gwansik Wrote Poems for the Writing Contest

Jejumok Gwana is where the writing contest in the drama took place. It was the administrative center of Jeju during the Joseon Dynasty and is a nationally designated heritage site and a representative historical and cultural tourist attraction in Jeju. Aesoon and Gwansik sat in front of Yeonhuijeong Pavilion in this Gwana to write poems. It is also the place where the middle-aged Aesoon wrote a poem longing for her mother. Recently, it has become very popular among foreign tourists, as they can rent hanbok(traditional Korean clothing) from nearby rental shops. It is common to see tourists taking photos in hanbok in front of the traditional Korean houses.

LOTTE rent-a-car Welcomes Foreign Customers with Professional Staff, Coupon Packs, and Electric Vehicle Promotions

LOTTE rent-a-car operates professional staff who can provide consultations in foreign languages. The official website supports English, Chinese, and Japanese, allowing international customers to smoothly handle the entire process from vehicle reservation to contract management and consultation in their native language. This makes it easy for first-time visitors to Korea to use the rental car service.

For tourists who find driving on unfamiliar roads burdensome or have a lot of luggage, it is recommended to use the chauffeur service. Professional drivers familiar with the local road conditions will drive, allowing tourists to focus solely on the beautiful scenery of Jeju outside the window. A variety of vehicle types are available, from compact cars to vans, SUVs, and 11-seater and 15-seater vehicles. This service can be used upon reservation inquiry.

There are also various benefits provided to international tourists using LOTTE rent-a-car. The ‘Jeju Welcome Coupon Pack,’ which consists of benefits necessary for traveling in Jeju, is a new free service offered to customers using LOTTE rent-a-car’s short-term rental cars in Jeju. It provides discounts of up to 54% on popular tourist attractions in Jeju and LOTTE affiliates. A free charging promotion that provides a charging card for electric vehicle users is also being implemented for international customers. Jeju’s major tourist attractions are well-equipped with electric vehicle charging infrastructure, making it convenient to use electric vehicles.

LOTTE rental, stated, “We will continue to expand various customized services so that travelers from around the world can experience the beauty and sentiment of Jeju more conveniently,” adding, “LOTTE rent-a-car will continue to enhance trust and satisfaction as a brand that accompanies the journeys of global customers.”

LOTTE rental is South Korea’s leading rental company, providing integrated rental solutions across all fields, including automobiles, office automation equipment and industrial equipment. Its subsidiary, LOTTE rent-a-car, holds the top market share in the domestic rental car industry and offers extensive mobility services to domestic and international customers through over 220 branches nationwide and a global partnership network.

https://www.lotterentacar.net/hp/chn/reservation/index.do?LANG=chn  

About LOTTE rental

LOTTE rental, the only comprehensive rental company in Korea, provides better value with various business portfolios, including auto mobility services that encompass car life, business solution services that support more effi­cient businesses.

LOTTE rent-a-car is creating an innovative car life as the No.1 car rental brand. LOTTE rent-a-car G car, Korea’s ‑first car-sharing brand, is drawing a better mobility service.

LOTTE rental is moving forward as a mobility leader that connects customers’ precious lives.

For more information about LOTTE rental, please visit: https://www.lotterental.com/

LOTTE rent-a-car suggests a travel course following the famous scenes from the Netflix Series ‘When Life Gives You Tangerines’

  • LOTTE rent-a-car introduces Jeju travel destinations featured in the drama that captivated global viewers
  • Enhancing convenience for international travelers by providing dedicated staff for foreign customers and multilingual support
  •  Offering various services such as chauffeur-driven rental cars, welcome coupon packs, and free electric vehicle charging

SEOUL, South Korea, April 29, 2025 /PRNewswire/ — As the Netflix series ‘When Life Gives You Tangerines’ receives an enthusiastic response from global viewers, interest in Jeju Island, known as the ‘Hawaii of Korea’ and the backdrop of the drama, is increasing. With the peak travel season to Jeju from March to May, the number of foreign tourists looking to experience the unique nature of Jeju depicted in the drama is on the rise.

Jeju Island has many hidden gems that are difficult to access using public transportation alone, making rental cars essential. LOTTE rent-a-car, South Korea’s No.1 rental car brand, holds the top market share in the Korean rental car market and is the official partner of the global rental car brand Hertz, providing verified services. They offer a systematic service system and multilingual support platform for international customers.

LOTTE rent-a-car Jeju Auto House is located near Jeju International Airport. It is the largest single-location rental car facility in the country, with a fleet of 3,000 vehicles. Operating 365 days a year from 6 AM to 11 PM, it allows customers to pick up or return vehicles conveniently regardless of flight times. The proportion of foreign customers renting from LOTTE rent-a-car in Jeju is increasing every year. As of 2024, foreign customers account for 25.6% of the total customers at LOTTE rent-a-car Jeju Auto House, meaning one in four customers is a foreigner.

For international tourists planning a trip to Jeju in the first half of this year, LOTTE rent-a-car suggests a special Jeju travel course centered around the filming locations of iconic scenes from the drama. These include Gimnyeong Beach, where young Aesoon eagerly waited for her mother, and Seongsan Ilchulbong, which showcases the beautiful scenery of Jeju.

Gimnyeong Beach: A Pristine Beach Embodying the Lives of female divers

Located in eastern Jeju, Gimnyeong Beach gained attention as the setting for the lives of haenyeo(female divers) in the drama. The exotic landscape, where cobalt blue waters, white sandy beaches, and black basalt rocks harmonize, leaves visitors in awe. Not only can you experience the local haenyeo culture, but you can also enjoy various marine activities such as yachting, kayaking, and snorkeling. The walking trail along the wind turbines lined up on the eastern side of the beach and the nearby cave exploration course add a unique charm.

Seongsan Ilchulbong: A UNESCO World Heritage Site and Sunrise Spot

Seongsan Ilchulbong, where the protagonist Aesoon performs 3,000 bows in the drama, is one of Jeju’s most iconic natural landmarks. Formed by underwater volcanic activity about 5,000 years ago, its cratered terrain is notable. This site is recognized as a UNESCO World Natural Heritage due to its geological significance and is also famous for its breathtaking sunrise views over the open sea. The magnificent scenery, where the blue sea and cliffs blend, leaves a lasting impression on both drama fans and general tourists.

Ora-dong Buckwheat Field: A Healing Photo Spot with Different Faces Each Season

The buckwheat flower path where Aesoon and Gwansik shared memories in the drama was filmed in the buckwheat fields of Ora-dong, Jeju City. The vast field, equivalent to 130 soccer fields, offers different charms each season, making it an ideal photo spot, especially for wedding photos. In spring, yellow canola flowers, in summer, pure white buckwheat flowers adorn the field, and from late winter to spring, the landscape is filled with green barley and reeds. May and June are the best times to witness the most splendid scenery.

Jejumok Gwana: Where Aesoon and Gwansik Wrote Poems for the Writing Contest

Jejumok Gwana is where the writing contest in the drama took place. It was the administrative center of Jeju during the Joseon Dynasty and is a nationally designated heritage site and a representative historical and cultural tourist attraction in Jeju. Aesoon and Gwansik sat in front of Yeonhuijeong Pavilion in this Gwana to write poems. It is also the place where the middle-aged Aesoon wrote a poem longing for her mother. Recently, it has become very popular among foreign tourists, as they can rent hanbok(traditional Korean clothing) from nearby rental shops. It is common to see tourists taking photos in hanbok in front of the traditional Korean houses.

LOTTE rent-a-car Welcomes Foreign Customers with Professional Staff, Coupon Packs, and Electric Vehicle Promotions

LOTTE rent-a-car operates professional staff who can provide consultations in foreign languages. The official website supports English, Chinese, and Japanese, allowing international customers to smoothly handle the entire process from vehicle reservation to contract management and consultation in their native language. This makes it easy for first-time visitors to Korea to use the rental car service.

For tourists who find driving on unfamiliar roads burdensome or have a lot of luggage, it is recommended to use the chauffeur service. Professional drivers familiar with the local road conditions will drive, allowing tourists to focus solely on the beautiful scenery of Jeju outside the window. A variety of vehicle types are available, from compact cars to vans, SUVs, and 11-seater and 15-seater vehicles. This service can be used upon reservation inquiry.

There are also various benefits provided to international tourists using LOTTE rent-a-car. The ‘Jeju Welcome Coupon Pack,’ which consists of benefits necessary for traveling in Jeju, is a new free service offered to customers using LOTTE rent-a-car’s short-term rental cars in Jeju. It provides discounts of up to 54% on popular tourist attractions in Jeju and LOTTE affiliates. A free charging promotion that provides a charging card for electric vehicle users is also being implemented for international customers. Jeju’s major tourist attractions are well-equipped with electric vehicle charging infrastructure, making it convenient to use electric vehicles.

LOTTE rental, stated, “We will continue to expand various customized services so that travelers from around the world can experience the beauty and sentiment of Jeju more conveniently,” adding, “LOTTE rent-a-car will continue to enhance trust and satisfaction as a brand that accompanies the journeys of global customers.”

LOTTE rental is South Korea’s leading rental company, providing integrated rental solutions across all fields, including automobiles, office automation equipment and industrial equipment. Its subsidiary, LOTTE rent-a-car, holds the top market share in the domestic rental car industry and offers extensive mobility services to domestic and international customers through over 220 branches nationwide and a global partnership network.

https://www.lotterentacar.net/hp/chn/reservation/index.do?LANG=chn

About LOTTE rental

LOTTE rental, the only comprehensive rental company in Korea, provides better value with various business portfolios, including auto mobility services that encompass car life, business solution services that support more effi­cient businesses.

LOTTE rent-a-car is creating an innovative car life as the No.1 car rental brand. LOTTE rent-a-car G car, Korea’s ‑first car-sharing brand, is drawing a better mobility service.

LOTTE rental is moving forward as a mobility leader that connects customers’ precious lives.

For more information about LOTTE rental, please visit: https://www.lotterental.com/

We need bold leadership to address complex social problems

SYDNEY, April 29, 2025 /PRNewswire/ — Health Justice Australia is calling on the next government of Australia to show bold political leadership in addressing the complex challenges many people in our community experience.

“More than ever, people in our community are facing interconnected health, social and justice issues that can have lifelong, intergenerational impacts on health and wellbeing. The challenges are significant: cost of living pressures, housing insecurity, increasing poverty, persistent gender inequality and gender-based violence, and increased risk from natural disaster and pandemics,” says Health Justice Australia CEO, Sheree Limbrick.

“Legal, health and social services are struggling to meet increasing demand for support, and individual service approaches do not have the capacity to respond to the complexity and interconnectedness of the problems people are experiencing.

“We urge the next government to invest in responses to these persistent problems through wraparound, person-centred services; early intervention and prevention; and First Nations self-determination.”

Health Justice Australia calls on our next government to:

1. Ensure strong, equitable and person-centred services that respond to multiple government priorities

The government must commit to long-term funding for preventive, integrated, multi-disciplinary services that address the social determinants of health; invest in the legal assistance sector to support an increase in integrated service delivery; and invest in workforce training to support multi-disciplinary practice.

2. Deliver resourcing to achieve First Nations self-determination

The government must adequately recognise and resource Aboriginal and Torres Strait Islander leadership, invest in Aboriginal Community Controlled Organisations, and continue towards community-led transition of policy and service leadership.

3. Invest in prevention and early intervention and the wider determinants of health

The government should deliver 5% of total health expenditure on preventative health as outlined in the National Preventive Health Strategy; and raise the rate of JobSeeker and related payments to provide a basic living wage.

View Health Justice Australia’s election priorities here.

Visit the Health Justice Australia website for more information on health justice partnership.

LG Energy Solution Establishes Battery Recycling Joint Venture with Derichebourg

  • Companies to build pre-processing facility in northern France to extract ‘black mass.’
  • Construction to begin in 2026; operations to commence in 2027
  • LG Energy Solution marks a critical first step toward a closed-loop system in Europe to strengthen value chain competitiveness.

SEOUL, South Korea, April 29, 2025 /PRNewswire/ — LG Energy Solution has announced plans to establish a joint venture with Derichebourg, the French leader in metal waste recycling, to build a state-of-the-art battery recycling plant.

Construction will begin in 2026 in Bruyères-sur-Oise, located in the Val-d’Oise region of northern France, with operations scheduled to commence in 2027.

The new plant will specialize in pre-processing, such as discharging, dismantling and shredding battery scrap—waste generated during battery production—as well as the collection of end-of-life EV batteries.

Marking LG Energy Solution’s first battery recycling joint venture in Europe, this state-of-the-art facility will have a processing capacity of over 20,000 tons per year at its full operation.

The black mass extracted at the pre-processing facility will undergo further post-processing to recover key battery raw materials such as lithium, nickel, and cobalt, which will then be used in LG Energy Solution’s battery production.

Under the agreement, LG Energy Solution will supply battery scrap from its facility in Poland, while Derichebourg will provide end-of-life EV batteries collected from France and surrounding countries.

Through this joint venture, LG Energy Solution is accelerating the development of a closed-loop[1] resource circulation system in Europe. This aligns with the company’s goals to enhance raw material sourcing stability and strengthen its value chain competitiveness, while reinforcing Europe’s sustainable battery recycling ecosystem.

Considering the EU Battery Regulation, which mandates a minimum level of recycled content in batteries sold in Europe starting in 2031, this partnership will also effectively address upcoming regulatory requirements. In addition, the collaboration aims to support car manufacturers seeking to establish a closed-loop battery recycling system, further promoting a circular economy.

Derichebourg operates over 200 collecting sites in France and over 285 sites worldwide. LG Energy Solution and Derichebourg plan to deepen their strategic partnership and expand their joint efforts in the battery recycling business.

“This collaboration enables us to secure a stable and cost-competitive supply of recycled battery materials from the advanced processing of end-of-life batteries and battery scrap,” said Chang Beom Kang, CSO of LG Energy Solution. “This initiative will also significantly enhance the value we deliver to customers in the recycling sector.”

“This partnership fully supports our ambition to develop industrial solutions with a high environmental added value, while strengthening the local roots of our activities,” said Abderrahmane El Aoufir, CEO of Derichebourg.

[1] Closed-loop system: Enables the recycling of used batteries and the reuse of recovered materials in new battery production.

About LG Energy Solution

LG Energy Solution (KRX: 373220), a split-off from LG Chem, is a leading global manufacturer of lithium-ion batteries for electric vehicles, mobility, IT, and energy storage systems. With 30 years of experience in revolutionary battery technology and extensive research and development (R&D), the company is the top battery-related patent holder in the world with over 69,600 patents. Its robust global network, which spans North America, Europe, and Asia, includes battery manufacturing facilities established through joint ventures with major automakers. Committed to building sustainable battery ecosystem, LG Energy Solution aims to achieve carbon neutrality across its value chain by 2050, while embodying the value of shared growth and promoting diverse and inclusive corporate culture. To learn more about LG Energy Solution’s ideas and innovations, visit https://news.lgensol.com.

AI Evolution and Life Sciences: Embracing New Frontiers at Dalton Venture CEO Summit 2025

 HONG KONG, April 29, 2025 /PRNewswire/ — Dalton Venture CEO Summit 2025 , jointly hosted by Dalton Venture and Hong Kong Science and Technology Parks Corporation (HKSTP), successfully concluded at Hong Kong Science Park. The summit brought together over 100 distinguished guests, including government officials, leading scholars, entrepreneurs, and investors from Mainland China, Hong Kong, and beyond, to explore new global opportunities in life sciences innovation.

Professor Han Sirui of HKUST, delegated by Chief Vice President Guo Yike, delivers a keynote speech at the summit.
Professor Han Sirui of HKUST, delegated by Chief Vice President Guo Yike, delivers a keynote speech at the summit.

The event gathered more than 60 entrepreneurs from Dalton Venture’s portfolio companies across cutting-edge sectors such as cell and gene therapy, ophthalmology, AI in healthcare, embodied AI, bio-3D-printing, and cardiovascular technologies.

Uniting Industry, Research, and Capital to Accelerate Globalization

Founding Managing Partner Sun Qi highlighted Hong Kong’s unique advantages as an East-West bridge, with world-class research infrastructure and capital markets. “Dalton Venture sees Hong Kong not only as a gateway to the world but as a convergence point for technology, capital, industry, and vision,” as he said.

Ms. Cheong Man Lei, Lillian, JP, Deputy Secretary for Innovation, Technology and Industry of the Hong Kong SAR Government, delivered a video keynote address. She emphasized Hong Kong’s commitment to becoming an international innovation and technology hub, citing initiatives like the HK$10 billion Research, Academic and Industry Sectors One-plus Scheme. She warmly welcomed more Mainland Chinese enterprises to leverage Hong Kong’s platform for international expansion.

Hong Kong Science Park as a Launchpad for Life Sciences Innovation

Ms. Gracie Ng, Chief of Staff and Acting Chief Corporate Development Officer of HKSTP, also extended a warm welcome. She highlighted HKSTP’s role in cultivating a vibrant life sciences ecosystem through research support, incubation services, and funding channels, including its HK$1 billion corporate venture fund. “We are delighted to host Dalton Venture’s CEO Summit and look forward to deepening collaboration with visionary enterprises.”

Capital Empowering Innovation: Insights from HKEX

Sam S.K. Luk, Vice President (Global Issuer Services) at Hong Kong Exchanges and Clearing Limited (HKEX), outlined Hong Kong’s latest initiatives to support biotech and hard-tech enterprises through listing mechanisms like Chapter 18A and 18C. He emphasized that Hong Kong remains a preferred destination for innovative companies seeking global investors, citing recent resilience in the local stock market and continued inflows from Southbound trading under the Stock Connect program.

Thought Leadership on Frontier Technologies

The summit also featured keynote speeches from leading scientists and entrepreneurs.

Professor Lam Hon Ming, Distinguished Professor of Life Sciences at The Chinese University of Hong Kong, and Director of the State Key Laboratory of Agrobiotechnology shared insights on agricultural biotechnology and sustainability.

Professor Sirui Han, representing Professor Guo Yike, Chief Vice President of the Hong Kong University of Science and Technology and Director of the Hong Kong Center for Generative Artificial Intelligence Research and Development, discussed the evolution of large AI models and their transformative impact on life sciences.

Strengthening Cross-Border Innovation Bridges

Prior to the summit, Dalton Venture organized a closed-door dialogue with InvestHK and the Office for Attracting Strategic Enterprises (OASES), connecting over 30 Mainland biotech companies with Hong Kong’s innovation and policy resources. Discussions focused on leveraging Hong Kong as a springboard for global clinical development, regulatory pathways, and international fundraising.

Looking Ahead: Building a Global Innovation Network

Mr. Huang Ning, Founding Partner of Dalton Venture, concluded the summit by reaffirming Dalton’s commitment to empowering entrepreneurs and accelerating the globalization of life sciences innovation.

As innovation continues to reshape the life sciences sector, Dalton Venture remains dedicated to fostering a robust, interconnected ecosystem that links research, capital, and industry across borders — advancing healthcare for a better future.

CONTACT
Name: Lynn Ning
Email: ningx@daltonventure.cn

Telix’s Illuccix PSMA-PET Imaging Agent Approved in France

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent

MELBOURNE, Australia, April 29, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing authorization in France by ANSM[2] for the detection and localization of prostate-specific membrane antigen (PSMA)-positive lesions in adults with prostate cancer, a broad clinical label.

Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane antigen (PSMA)-positive lesions with PET in adults with prostate cancer (PCa) in the following clinical settings:

  • Primary staging of patients with high-risk PCa prior to primary curative therapy.
  • Suspected recurrent PCa in patients with increasing levels of serum prostate-specific antigen (PSA) after primary curative therapy.
  • Identification of patients with PSMA-positive progressive metastatic castration-resistant prostate cancer (mCRPC) for whom PSMA-targeted therapy is indicated.

PSMA-PET[3] imaging represents a significant advancement in prostate cancer management, providing clinicians with more information than conventional imaging methods (bone scan, CT[4] scan) thereby offering a new standard of care after initial diagnosis and biochemical recurrence (BCR). Global guidelines recognise its superior accuracy in staging primary disease and assessing BCR/biochemical persistence (BCP)[5]. Illuccix® PSMA-PET will help address an important clinical need by supporting timely and effective diagnosis, as well as identifying patients who may benefit from PSMA-targeted therapy.

Illuccix’s broad approval is supported by robust clinical data, including the largest Ga-68-based PSMA data set from the VISION trial[6]. The approval of Illuccix® in France has the potential to resolve access challenges by enabling hospitals and clinics to prepare PSMA-PET scans on-site, offering physicians a quicker, more accessible solution.

Professor Frédéric Courbon, Head of the Medical Imaging Department – University Cancer Institute of Toulouse – Oncopole, commented, “PSMA-PET imaging is dramatically changing prostate cancer patient management. Thus, equitable and reliable access to PSMA-PET across France is essential.The approval of Illuccix® in France will address some of the access challenges, and reduce the risk of delayed diagnosis, with a readily available option for effective disease management.”

With its broad indication and ready-to-use formulation, Illuccix® is designed to support healthcare providers in delivering efficient and reliable imaging. The approval comes as demand for PSMA-PET continues to grow across Europe, reinforcing the need for solutions that fit within existing hospital workflows.

“The approval of Illuccix in France will enable a clinically validated PSMA-PET product to be more widely available, allowing healthcare providers to benefit from the convenience and flexibility of generator-produced gallium. This milestone reinforces our ongoing commitment to advancing prostate cancer care and expanding access to innovative diagnostic technologies across Europe,” said Raphaël Ortiz, Chief Executive Officer, Telix International.

Telix will partner with IRE ELiT S.A. (the radiopharmaceutical subsidiary of IRE Group), a leading provider of radioisotopes and radiopharmaceuticals for nuclear medicine, for the marketing and promotion of Illuccix® to healthcare professionals in France.

Jean Bonnet, Head of Strategy, Sales and Marketing, IRE EliT added: “We are pleased to collaborate with Telix and bring our expertise to expanding the availability of Illuccix throughout France. We are committed to ensuring that clinicians have access to reliable PSMA-PET imaging technologies to improve the lives of people living with prostate cancer.”

– ENDS –

Notes to editors

  • French healthcare professionals interested in ordering Illuccix® or learning more about availability can contact Eric Rizzo: eric.rizzo@ire-elit.eu 

Prostate Cancer in France

Prostate cancer is the most common cancer in men in France, with over 57,000 new cases diagnosed annually, and a significantly higher incidence in men than either lung cancer (32,800 new cases) or bowel cancer (27,000 new cases). Prostate cancer is also a common cause of cancer death in men, with over 9,200 men dying from their disease in France in 2022[7].

About Illuccix®  

Telix’s prostate imaging product, gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)[8], by the Australian Therapeutic Goods Administration (TGA)[9], by Health Canada[10], by the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA)[11], by the French ANSM, and in multiple other European Economic Area (EEA) Member States[12]. Illuccix® is currently in national approval review across the European Economic Area following a positive decentralized procedure (DCP) opinion by BfArM[13].

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. ARTMS, IsoTherapeutics, Lightpoint, Optimal Tracers and RLS are Telix Group companies. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Telix’s osteomyelitis (bone infection) imaging agent, technetium-99m (99mTc) besilesomab, marketed under the brand name Scintimun®, is approved in 32 European countries and Mexico. Telix’s miniaturized surgical gamma probe, SENSEI®, for minimally invasive and robotic-assisted surgery, is registered with the FDA for use in the U.S. and has attained a Conformité Européenne (CE) Mark for use in the European Economic Area. No other Telix product has received a marketing authorization in any jurisdiction.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and SEC filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedInX and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Legal Notices

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

©2025 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Telix Group company, and Telix product names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. Trademark registration status may vary from country to country.

[1] Positron emission tomography.

[2] National Agency for the Safety of Medicine and Health Products (Agence nationale de sécurité du médicament et des produits de santé).

[3] Imaging of prostate-specific membrane antigen with positron emission tomography.

[4] Computed tomography.

[5] European Association of Urology (EAU) Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. ISBN 978-94-92671-23-3.: https://uroweb.org/guidelines/prostate-cancer;  Prostate cancer: European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2023: https://www.esmo.org/guidelines/guidelines-by-topic/esmo-clinical-practice-guidelines-genitourinary-cancers/clinical-practice-guidelines-prostate-cancer/eupdate-prostate-cancer-treatment-recommendations

[6] ClinicalTrials.gov ID: NCT03511664. VISION study sponsored by Endocyte, a Novartis company. Telix provided Illuccix® (TLX591-CDx) for PSMA-PET imaging.

[7] Global Cancer Statistics 2022: GLOBOCAN survey. Published August 2024.

[8] Telix ASX disclosure 20 December 2021.

[9] Telix ASX disclosure 2 November 2021.

[10] Telix ASX disclosure 14 October 2022.

[11] Telix ASX disclosure 13 February 2025.

[12] Denmark, Ireland, Luxembourg, Malta, the Netherlands, Norway and Sweden at time of release.

[13] The German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte). Telix ASX disclosure 17 January 2025.